It’s a tough climate for raising capital - our Oxford spinout companies are working hard to deliver impressive results. The OUI team recently travelled to the JPM Healthcare conference in San Francisco to connect our spinout leaders with US and global life science investors.
This year, around 100,000 people in the UK will have a stroke. AI algorithms developed by Oxford University spinout Brainomix are ensuring that more of those patients will receive better care and better outcomes.
Oxford University Innovation (OUI) welcomes the Independent Review of University Spin-out companies, published today.
Pioneering a future of informed decisions: how Prolific is shaping the next wave of research and AI training with human-centric, quality data across the globe.
The second year of the Jamies Awards deliver ideas that tackle plastic waste, drug discovery, and bad coffee.
Taking command of OUI's Consulting Services unit during the pandemic, Jaci Barnett has led the group to new heights. Discover how she's led Team CS to growth since her arrival.
Charting a vibrant future for the Oxford Innovation Society (OIS), Louise Male and Andrea Stewart spark a call to action for a collective, co-created evolution of this historic network. Engage in shaping an innovation hub where useful collaborations, diverse engagements, and a novel digital interface drive the next wave of breakthroughs in Oxford's dynamic ecosystem.
AI-based music generation platform SoulChord takes the crown at this year's Student Entrepreneurship Programme.
For the latest in our CEO Spotlight series, we caught up with Dr Tony Coombs, Executive Chairman of Oxford VacMedix - a spinout company making waves in the world of cancer vaccines with its impressive pre-clinical and Phase 1 trial results.
